CD274 and non-small cell lung carcinoma: In NSCLC, the combination therapy has been studied in trials like NCT02477826 and NCT03215706, where it was observed that patients had significantly better PFS and OS, compared with chemotherapy, regardless of PDL1 status [243,244].